Korean J Gastroenterol.  2006 Jul;48(1):46-50.

Portal and Superior Mesenteric Venous Thrombosis Treated with Urokinase Infusion via Superior Mesenteric Artery

  • 1Division of Gastroenterology, Departments of Internal Medicine, St. Mary's Hospital, The Catholic University of Korea College of Medicine, Seoul, Korea. jyhan@catholic.ac.kr
  • 2Departments of Radiology, St. Mary's Hospital, The Catholic University of Korea College of Medicine, Seoul, Korea


Portal and mesenteric venous thrombosis is an uncommon disease, but clinically important, because it accounts for 5% to 15% of acute mesenteric ischemia. The diagnosis is often delayed because the conditions are nonspecific abdominal symptoms. In addition, when this occurs in young individual without any known predisposing factor, the diagnosis may become even more difficult. The treatment of mesenteric venous thrombosis involves anticoagulation therapy alone or in combination with surgery. The addition of thrombolytic therapy to the treatment of portal and mesenteric venous thrombosis may enhance the clearance of thrombus and hasten the clinical improvements. We present a case of mesenteric venous thrombosis treated with catheter-directed infusion of urokinase via the superior mesenteric artery and systemic anticoagulation.


Mesenteric venous thrombosis; Urokinase

MeSH Terms

Infusions, Intra-Arterial
Mesenteric Artery, Superior
Mesenteric Vascular Occlusion/*drug therapy
Mesenteric Veins
*Portal Vein
*Thrombolytic Therapy
Urokinase-Type Plasminogen Activator/*administration & dosage
Venous Thrombosis/*drug therapy
Full Text Links
  • KJG
export Copy
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr